Page last updated: 2024-09-03

as 35 and leukotriene b4

as 35 has been researched along with leukotriene b4 in 1 studies

Compound Research Comparison

Studies
(as 35)
Trials
(as 35)
Recent Studies (post-2010)
(as 35)
Studies
(leukotriene b4)
Trials
(leukotriene b4)
Recent Studies (post-2010) (leukotriene b4)
9005,886232717

Protein Interaction Comparison

ProteinTaxonomyas 35 (IC50)leukotriene b4 (IC50)
Leukotriene B4 receptor 1Homo sapiens (human)0.0019

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamasaki, Y; Hayasaki, R; Ichimaru, T; Kobayashi, I; Matsuo, M; Miyazaki, M; Miyazaki, S; Muro, E; Tsuji, K; Yamamoto, S; Zaitu, M1

Other Studies

1 other study(ies) available for as 35 and leukotriene b4

ArticleYear
(9-[4-acetyl-3-hydroxy-2-n-propylphenoxy) methyl]-3-(1H-tetrazol-5-yl)-4H-pyrido [1,2-a] pyrimidin-4-one), AS-35, inhibits leukotriene synthesis.
    International journal of immunopharmacology, 2000, Volume: 22, Issue:7

    Topics: Animals; Arachidonic Acid; beta-N-Acetylhexosaminidases; Cell-Free System; Cytosol; Leukotriene A4; Leukotriene Antagonists; Leukotriene B4; Leukotriene C4; Phospholipases A; Pyridines; Pyrimidinones; Rats; Substrate Specificity; Tetrazoles; Tumor Cells, Cultured

2000